The purpose of this study was to evaluate the diagnostic potential of decision-tree model of diffusion kurtosis imaging (DKI) and 11C-methionine (11C-MET) PET imaging, for the differentiation of radiotherapy injury from glioblastoma recurrence using integrated PET/MR. Eighty-six glioblastoma cases with suspected lesions after radiotherapy were retrospectively enrolled. Compared to models of DKI-alone (AUC=0.85) and PET-alone (AUC=0.89), the combined model demonstrated the best diagnostic accuracy (AUC=0.95). The decision-tree model has the potential to further increase diagnostic accuracy for discrimination between radiotherapy injury and glioblastoma recurrence. 11C-MET PET/MR may thus contribute to the management of glioblastoma patients with suspected lesions after radiotherapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords